Тяжелая внебольничная пневмония у взрослых. Клинические рекомендации Федерации анестезиологов и реаниматологов России

СН Авдеев, ВБ Белобородов… - Анестезиология и …, 2022 - elibrary.ru
Цель обновленных клинических рекомендаций состоит в представлении
специалистам, в первую очередь анестезиологам-реаниматологам, современных …

Identification, Screening and Antibacterial Mechanism Analysis of Novel Antimicrobial Peptides from Sturgeon (Acipenser ruthenus) Spermary

HL Li, YN Chen, J Cai, T Liao, XY Zu - Marine Drugs, 2023 - mdpi.com
Fish is an important source of antimicrobial peptides. This study aimed to identify and screen
antibacterial peptides with excellent antibacterial activity derived from sturgeon spermary …

A Fatal Case of Pseudomonas aeruginosa Community-Acquired Pneumonia in an Immunocompetent Patient: Clinical and Molecular Characterization and Literature …

N Barp, M Marcacci, E Biagioni, L Serio, S Busani… - Microorganisms, 2023 - mdpi.com
Rare cases of Pseudomonas aeruginosa community-acquired pneumonia (PA-CAP) were
reported in non-immunocompromised patients. We describe a case of Pseudomonas …

Priming with intranasal lactobacilli prevents Pseudomonas aeruginosa acute pneumonia in mice

MS Fangous, P Gosset, N Galakhoff, S Gouriou… - BMC microbiology, 2021 - Springer
Background Increasing resistance to antibiotics of Pseudomonas aeruginosa leads to
therapeutic deadlock and alternative therapies are needed. We aimed to evaluate the effects …

Aspiration pneumonia in older adults

A Makhnevich, KH Feldhamer, CL Kast… - Journal of Hospital …, 2019 - Wiley Online Library
Aspiration pneumonia refers to an infection of the lung parenchyma in an individual that has
inhaled a bolus of endogenous flora that overwhelms the natural defenses of the respiratory …

Microbiology of Severe Community-Acquired Pneumonia and the Role of Rapid Molecular Techniques

CI Pickens, CA Gao, L Morales-Nebreda… - … in Respiratory and …, 2024 - thieme-connect.com
The microbiology of severe community acquired pneumonia (SCAP) has implications on
management, clinical outcomes and public health policy. Therefore, knowledge of the …

In-vitro activity of ceftolozane/tazobactam against Pseudomonas aeruginosa collected in the Study for Monitoring Antimicrobial Resistance Trends (SMART) between …

W Yu, H Zhang, Y Zhu, PY Jia, YC Xu… - International Journal of …, 2023 - Elsevier
Ceftolozane/tazobactam (an antipseudomonal cephalosporin) in combination with a well-
established β-lactamase inhibitor has not been approved to date in clinical practice in …

Management strategies for severe Pseudomonas aeruginosa infections

H Do Rego, JF Timsit - Current Opinion in Infectious Diseases, 2023 - journals.lww.com
Carbapenem resistance in difficult-to-treat P. aeruginosa (DTR-PA) strains is primarily
mediated by loss or reduction of the OprD porin, overexpression of the cephalosporinase …

Advances in Understanding of the Copper Homeostasis in Pseudomonas aeruginosa

L Hofmann, M Hirsch, S Ruthstein - International Journal of Molecular …, 2021 - mdpi.com
Thirty-five thousand people die as a result of more than 2.8 million antibiotic-resistant
infections in the United States of America per year. Pseudomonas aeruginosa (P …

Pseudomonas aeruginosa pneumonia: evolution of antimicrobial resistance and implications for therapy

JP Lynch III, GG Zhanel - Seminars in Respiratory and Critical …, 2022 - thieme-connect.com
Pseudomonas aeruginosa (PA), a non–lactose-fermenting gram-negative bacillus, is a
common cause of nosocomial infections in critically ill or debilitated patients, particularly …